                         SEQUENCE LISTING

<110>  O'Shaughnessey, William S
       Loose, Christopher S
       Hencke, Michael
       Wood, Kris
       Squier, Trevor
       Zhang, Zheng
 
<120>  NON-LEACHING, NON-FOULING ANTIMICROBIAL COATINGS

<130>  STER 100

<160>  9     

<170>  PatentIn version 3.3

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  1

Gln Xaa Glu Ala Gly Xaa Leu Xaa Lys Xaa Lys Xaa 
1               5                   10          


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic antimicrobial peptide (Cecropin-Melittin Hybrid)


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Aminated

<400>  2

Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu 
1               5                   10                  15  


<210>  3
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic antimicrobial sequence (D28)

<400>  3

Phe Leu Gly Val Val Phe Lys Leu Ala Ser Lys Val Phe Pro Ala Val 
1               5                   10                  15      


Phe Gly Lys Val 
            20  


<210>  4
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic antimicrobial peptide (D51)

<400>  4

Phe Leu Phe Arg Val Ala Ser Lys Val Phe Pro Ala Leu Ile Gly Lys 
1               5                   10                  15      


Phe Lys Lys Lys 
            20  


<210>  5
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic antimicrobial peptide (MICL-1)


<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Aminated

<400>  5

Gly Ile Gly Lys Phe Leu Lys Lys Ala Lys Lys Phe Gly Lys Ala Phe 
1               5                   10                  15      


Val Lys Ile Leu Lys Lys 
            20          


<210>  6
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic antimicrobial sequence (MICL-41)


<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Aminated

<400>  6

Arg Gly Leu Arg Arg Leu Gly Arg Lys Ile Ala His Gly Val Lys Lys 
1               5                   10                  15      


Tyr Gly Pro Thr Val Leu Arg Ile Ile Arg Ile Ala Gly 
            20                  25                  


<210>  7
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic antimicrobial peptide (MICL-42)


<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Aminated

<400>  7

Gly Trp Lys Asp Trp Ala Lys Lys Ala Gly Gly Trp Leu Lys Lys Lys 
1               5                   10                  15      


Gly Pro Gly Met Ala Lys Ala Ala Leu Lys Ala Ala Met Gln 
            20                  25                  30  


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic cysteine-incorporating Cecropi-Melittin hybrid peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  aminated

<400>  8

Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu Cys 
1               5                   10                  15      


<210>  9
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic cysteine-incorporating Cecropin-melittin hybrid peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aminated

<400>  9

Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu Cys 
1               5                   10                  15      


